U.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen.

The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ARS Pharmaceuticals ...

In a first, the US Food and Drug Administration has approved ARS pharmaceuticals' nasal spray as the first needle-free emergency treatment for fatal allergic reactions called anaphylaxis. The ...

The Neffy nasal spray treats adults and children and could help the more than 1 in 3 U.S. adults reported to have a seasonal or food allergy.

U.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen. The Food and Drug Administration said it approved ...

U.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen.

FDA approves first nasal spray to treat dangerous allergic reactions The device could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers.